References
- Alikian M, Gerrard G, Subramanian PG, et al (2012). BCRABL1 kinase domain mutations: Methodology and clinical evaluation. Am J Hematol, 87, 298-304. https://doi.org/10.1002/ajh.22272
- Benetatos L, Hatzimichael E, Londin E, et al (2013). The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol Life Sci, 70, 795-814. https://doi.org/10.1007/s00018-012-1080-8
- Chen HY, Lin YM, Chung HC, et al (2012). miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res, 72, 3631-41. https://doi.org/10.1158/0008-5472.CAN-12-0667
- Druker BJ, Guilhot F, O'Brien SG, et al (2006). Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. New Engl J Med, 355, 2408-17. https://doi.org/10.1056/NEJMoa062867
- Ernst A, Hofmann S, Ahmadi R, et al (2009). Genomic and Expression Profiling of Glioblastoma Stem Cell-Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival. Clin Cancer Res, 15, 6541-50. https://doi.org/10.1158/1078-0432.CCR-09-0695
- Ernst T, Hochhaus A (2012). Chronic Myeloid Leukemia: Clinical Impact of BCR-ABL1 Mutations and Other Lesions Associated With Disease Progression. Semin Oncol, 39, 58-66. https://doi.org/10.1053/j.seminoncol.2011.11.002
- Fabbri M, Paone A, Calore F, et al (2012). MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A, 109, E2110-6. https://doi.org/10.1073/pnas.1209414109
- Fountzilas E, Kelly AD, Perez-Atayde AR, et al (2012). A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic study. BMC Genomics, 13, 332. https://doi.org/10.1186/1471-2164-13-332
- Ge R, Tan E, Sharghi-Namini S, et al (2012). Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers? Cancer Microenviron, 5, 323-32. https://doi.org/10.1007/s12307-012-0110-2
- Gkretsi V, Zhang YJ, Tu YZ, et al (2005). Physical and functional association of migfilin with cell-cell adhesions. J Cell Sci, 118: 697-710. https://doi.org/10.1242/jcs.01638
- Henderson MC, Azorsa DO (2012). The genomic and proteomic content of cancer cell-derived exosomes. Front Oncol, 2, 38.
- Hu G, Drescher KM, Chen XM (2012). Exosomal miRNAs: Biological Properties and Therapeutic Potential. Front Genet, 3, 56.
- Hu H, Li Y, Gu J, et al (2010). Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells. Leuk Lymphoma, 51, 694-701. https://doi.org/10.3109/10428191003596835
- Khan NI, Bradstock KF, Bendall LJ (2007). Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Brit J Haematol, 138, 338-48. https://doi.org/10.1111/j.1365-2141.2007.06667.x
- Kharaziha P, Ceder S, Li Q, et al (2012). Tumor cell-derived exosomes: A message in a bottle[J]. Biochim Biophys Acta, 1826, 103-11.
- Liu L, Chen R, Huang S, et al (2012). miR-153 sensitized the K562 cells to As2O3-induced apoptosis. Med Oncol, 29, 243-7. https://doi.org/10.1007/s12032-010-9807-6
- Mineo M, Garfield SH, Taverna S, et al (2012). Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion. Angiogenesis, 15, 33-45. https://doi.org/10.1007/s10456-011-9241-1
- Munich S, Sobo-Vujanovic A, Buchser WJ, et al (2012). Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology, 1, 1074-83. https://doi.org/10.4161/onci.20897
- O'Brien K, Rani S, Corcoran C, et al (2013). Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. Eur J Cancer, 49, 1845-59. https://doi.org/10.1016/j.ejca.2013.01.017
- Ohshima K, Inoue K, Fujiwara A, et al (2010). Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One, 5, e13247. https://doi.org/10.1371/journal.pone.0013247
- Pallasch CP, Patz M, Park YJ, et al (2009). miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood, 114, 3255-64. https://doi.org/10.1182/blood-2009-06-229898
- Patnaik SK, Kannisto E, Knudsen S, et al (2010). Evaluation of MicroRNA Expression Profiles That May Predict Recurrence of Localized Stage I Non-Small Cell Lung Cancer after Surgical Resection. Cancer Res, 70, 36-45. https://doi.org/10.1158/0008-5472.CAN-09-3153
- Peinado H, Aleckovic M, Lavotshkin S, et al (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med, 18, 883-91. https://doi.org/10.1038/nm.2753
- Rao Q, Wang J-Y, Meng J, et al (2011). Low-expression of E-cadherin in leukaemia cells causes loss of homophilic adhesion and promotes cell growth. Cell Biol Int, 35, 945-51. https://doi.org/10.1042/CBI20100456
- Roberson CD, Atay S, Gercel-Taylor C, et al (2010). Tumorderived exosomes as mediators of disease and potential diagnostic biomarkers. Cancer Biomark, 8, 281-91.
- Roccaro AM, Sacco A, Maiso P, et al (2013). BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest, 123, 1542-55. https://doi.org/10.1172/JCI66517
- Rokah OH, Granot G, Ovcharenko A, et al (2012). Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. PLoS One, 7, e35501. https://doi.org/10.1371/journal.pone.0035501
- Savina A, Furlan M, Vidal M, et al (2003). Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem, 278, 20083-90. https://doi.org/10.1074/jbc.M301642200
- Tanaka M, Oikawa K, Takanashi M, et al (2009). Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients. PLoS One, 4, e5532. https://doi.org/10.1371/journal.pone.0005532
- Umezu T, Ohyashiki K, Kuroda M, et al (2013). Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene, 32, 2747-55. https://doi.org/10.1038/onc.2012.295
- Valadi H, Ekstrom K, Bossios A, et al (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 9, 654-9. https://doi.org/10.1038/ncb1596
- van Dommelen SM, Vader P, Lakhal S, et al (2012). Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery. J Control Release, 161, 635-44. https://doi.org/10.1016/j.jconrel.2011.11.021
- Vlassov AV, Magdaleno S, Setterquist R, et al (2012). Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta, 1820, 940-8. https://doi.org/10.1016/j.bbagen.2012.03.017
- Wahlgren J, Karlson Tde L, Glader P, et al (2012). Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling. PLoS One, 7, e49723. https://doi.org/10.1371/journal.pone.0049723
- Wang W, Zhao L-J, Tan Y-X, et al (2012). MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis, 33, 1113-20. https://doi.org/10.1093/carcin/bgs113
- Weisberg E, Sattler M, Ewaniuk DS, et al (1997). Role of focal adhesion proteins in signal transduction and oncogenesis. Crit Rev Oncogen, 8, 343-58. https://doi.org/10.1615/CritRevOncog.v8.i4.40
- Willis TG, Zalcberg IR, Coignet LJA, et al (1998). Molecular cloning of translocation t (1;14) (q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood, 91, 1873-81.
- Xiong F, Wu C, Chang J, et al (2011). Genetic Variation in an miRNA-1827 Binding Site in MYCL1 Alters Susceptibility to Small-Cell Lung Cancer. Cancer Res, 71: 5175-81. https://doi.org/10.1158/0008-5472.CAN-10-4407
- Yang C, Robbins PD (2011). The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol, 2011, 842-9.
- Zimmerman EI, Dollins CM, Crawford M, et al (2010). Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia. Mol Pharmacol, 78, 811-7. https://doi.org/10.1124/mol.110.066258
Cited by
- Construction of a Protein-Protein Interaction Network for Chronic Myelocytic Leukemia and Pathway Prediction of Molecular Complexes vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5325
- Elevated Serum Ferritin Levels in Patients with Hematologic Malignancies vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6099
- MicroRNAs as Potential Biomarkers in Acute Promyelocytic Leukaemia vol.2014, pp.2090-8520, 2014, https://doi.org/10.1155/2014/932342
- The fusion of two worlds: Non-coding RNAs and extracellular vesicles - diagnostic and therapeutic implications (Review) vol.46, pp.1, 2014, https://doi.org/10.3892/ijo.2014.2712
- Deciphering the cross-talking of human competitive endogenous RNAs in K562 chronic myelogenous leukemia cell line vol.12, pp.12, 2016, https://doi.org/10.1039/C6MB00568C
- ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression vol.13, pp.1, 2016, https://doi.org/10.1186/s12977-016-0307-4
- Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy vol.18, pp.6, 2017, https://doi.org/10.3390/ijms18061183
- Multiple Myeloma-Derived Exosomes Regulate the Functions of Mesenchymal Stem Cells Partially via Modulating miR-21 and miR-146a vol.2017, pp.1687-9678, 2017, https://doi.org/10.1155/2017/9012152
- Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics vol.6, pp.2167-8359, 2018, https://doi.org/10.7717/peerj.4763